Voyager Therapeutics (VYGR) Short Interest Ratio & Short Volume → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free VYGR Stock Alerts $7.62 +0.20 (+2.70%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Voyager Therapeutics Short Interest DataCurrent Short Volume3,460,000 sharesPrevious Short Volume3,330,000 sharesChange Vs. Previous Month+3.90%Dollar Volume Sold Short$28.51 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares54,300,000 sharesPercentage of Shares Shorted6.37%Today's Trading Volume345,051 sharesAverage Trading Volume899,206 sharesToday's Volume Vs. Average38% Short Selling Voyager Therapeutics ? Sign up to receive the latest short interest report for Voyager Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVYGR Short Interest Over TimeVYGR Days to Cover Over TimeVYGR Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Voyager Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,460,000 shares $28.51 million +3.9%N/A5.5 $8.24 3/31/20243,330,000 shares $31.00 million +44.2%N/A4.4 $9.31 3/15/20242,310,000 shares $21.44 million +2.2%N/A2.5 $9.28 2/29/20242,260,000 shares $18.80 million +5.1%N/A2.9 $8.32 2/15/20242,150,000 shares $16.53 million +9.1%5.9%3.1 $7.69 1/31/20241,970,000 shares $14.32 million +8.8%5.4%3 $7.27 Get the Latest News and Ratings for VYGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,810,000 shares $14.23 million +4.0%5.0%2.9 $7.86 12/31/20231,740,000 shares $14.69 million +1.8%N/A3.1 $8.44 12/15/20231,710,000 shares $13.65 million +3.0%4.9%8.5 $7.98 11/30/20231,660,000 shares $12.05 million -13.5%4.8%7.4 $7.26 11/15/20231,920,000 shares $12.92 million -4.5%5.5%8.3 $6.73 10/31/20232,010,000 shares $13.21 million -1.0%5.8%8.3 $6.57 10/15/20232,030,000 shares $15.00 million +1.0%5.9%7.7 $7.39 9/30/20232,010,000 shares $15.58 million +0.5%5.8%6.8 $7.75 9/15/20232,000,000 shares $15.92 million -3.9%5.7%6.1 $7.96 8/31/20232,080,000 shares $20.84 million +2.5%6.0%4.6 $10.02 8/15/20232,030,000 shares $19.29 million +4.1%5.8%3.8 $9.50 7/31/20231,950,000 shares $18.17 million -4.9%5.6%3 $9.32 7/15/20232,050,000 shares $19.50 million -2.4%6.0%3.1 $9.51 6/30/20232,100,000 shares $24.05 million +57.9%6.1%3.3 $11.45 6/15/20231,330,000 shares $17.52 million +10.8%3.9%2.2 $13.17 5/31/20231,200,000 shares $13.67 million +9.1%3.5%2.5 $11.39 5/15/20231,100,000 shares $11.44 million +7.8%3.2%2.5 $10.40 4/30/20231,020,000 shares $7.40 million No Change3.5%3 $7.25 4/15/20231,020,000 shares $8.23 million No Change3.5%3.5 $8.07 3/31/20231,020,000 shares $7.86 million No Change3.7%2.5 $7.71 3/15/20231,020,000 shares $8.18 million +23.0%3.7%2.6 $8.02 2/28/2023829,200 shares $5.95 million -1.7%3.3%2.3 $7.18 2/15/2023843,900 shares $6.40 million -1.9%3.4%2.7 $7.58 1/31/2023860,400 shares $8.12 million -21.8%3.1%2.9 $9.44 1/15/20231,100,000 shares $11.86 million +11.8%4.0%4.2 $10.78 12/30/2022983,600 shares $6.00 million +13.0%3.6%4.6 $6.10 12/15/2022870,200 shares $5.05 million +0.6%3.2%7 $5.80 11/30/2022865,100 shares $5.14 million -4.2%3.2%6.8 $5.94 11/15/2022902,700 shares $4.99 million -2.5%3.3%5.8 $5.53 10/31/2022926,200 shares $4.80 million +31.9%3.4%5 $5.18 10/15/2022702,300 shares $4.03 million -29.3%2.6%3.6 $5.74 9/30/2022993,400 shares $5.88 million -19.2%3.6%5 $5.92 9/15/20221,230,000 shares $8.25 million +12.8%4.5%5.9 $6.71 8/31/20221,090,000 shares $6.51 million +5.8%4.0%4.5 $5.97Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. VYGR Short Interest - Frequently Asked Questions What is Voyager Therapeutics' current short interest? Short interest is the volume of Voyager Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,460,000 shares of VYGR short. Learn More on Voyager Therapeutics' current short interest. What is a good short interest ratio for Voyager Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VYGR shares currently have a short interest ratio of 6.0. Learn More on Voyager Therapeutics's short interest ratio. Is Voyager Therapeutics' short interest increasing or decreasing? Voyager Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,460,000 shares, an increase of 3.9% from the previous total of 3,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Voyager Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Voyager Therapeutics: Lexeo Therapeutics, Inc. (5.21%), Replimune Group, Inc. (18.75%), iTeos Therapeutics, Inc. (7.43%), Tourmaline Bio, Inc. (11.58%), Editas Medicine, Inc. (22.81%), Adaptive Biotechnologies Co. (7.23%), Humacyte, Inc. (4.38%), Caribou Biosciences, Inc. (14.24%), Taysha Gene Therapies, Inc. (8.59%), C4 Therapeutics, Inc. (13.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Voyager Therapeutics stock? Short selling VYGR is an investing strategy that aims to generate trading profit from Voyager Therapeutics as its price is falling. VYGR shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Voyager Therapeutics? A short squeeze for Voyager Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYGR, which in turn drives the price of the stock up even further. How often is Voyager Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYGR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LXEO Short Squeeze REPL Short Squeeze ITOS Short Squeeze TRML Short Squeeze EDIT Short Squeeze ADPT Short Squeeze HUMA Short Squeeze CRBU Short Squeeze TSHA Short Squeeze CCCC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VYGR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe AI stock to buy right nowStockEarnings